tiprankstipranks
Trending News
More News >
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS

Aclaris Therapeutics (ACRS) Revenue

Compare
751 Followers

Aclaris Therapeutics Revenue

Aclaris Therapeutics had a revenue of 1.46M in the quarter ending Mar 31, 2025, with -84.20%. This bring the company's revenue in the last twelve months to 17.78M, Increased -5.04%. In the fiscal year ending Dec 31, 2024, Aclaris Therapeutics had annual revenue of 18.72M with -40.09% growth.
Revenue (ttm)
17.78M
Revenue Growth
-40.09%
P/S Ratio
8.33
Revenue/Employee
$306,885
Employees
61
Market Cap
$155.92M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
18.72M-12.53M-40.09%
Dec 31, 2023
31.25M1.50M+5.03%
Dec 31, 2022
29.75M22.99M+340.05%
Dec 31, 2021
6.76M279.00K+4.30%
Dec 31, 2020
6.48M2.25M+53.35%
Dec 31, 2019
4.23M-5.86M-58.11%
Dec 31, 2018
10.09M8.41M+499.58%
Dec 31, 2017
1.68M+∞%
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis